GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXAU) » Definitions » EV-to-EBIT

Lux Health Tech Acquisition (Lux Health Tech Acquisition) EV-to-EBIT : 0.00 (As of May. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lux Health Tech Acquisition's Enterprise Value is $0.00 Mil. Lux Health Tech Acquisition's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 was $-1.12 Mil. Therefore, Lux Health Tech Acquisition's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Lux Health Tech Acquisition's EV-to-EBIT or its related term are showing as below:

LUXAU' s EV-to-EBIT Range Over the Past 10 Years
Min: -395.04   Med: 0   Max: 0
Current: -386.99

LUXAU's EV-to-EBIT is not ranked
in the Diversified Financial Services industry.
Industry Median: 8.55 vs LUXAU: -386.99

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Lux Health Tech Acquisition's Enterprise Value for the quarter that ended in Jun. 2022 was $0.00 Mil. Lux Health Tech Acquisition's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 was $-1.12 Mil. Lux Health Tech Acquisition's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2022 was %.


Lux Health Tech Acquisition EV-to-EBIT Historical Data

The historical data trend for Lux Health Tech Acquisition's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition EV-to-EBIT Chart

Lux Health Tech Acquisition Annual Data
Trend Dec20 Dec21
EV-to-EBIT
- -357.30

Lux Health Tech Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EV-to-EBIT Get a 7-Day Free Trial - -371.32 -357.30 -391.87 -381.21

Competitive Comparison of Lux Health Tech Acquisition's EV-to-EBIT

For the Shell Companies subindustry, Lux Health Tech Acquisition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lux Health Tech Acquisition's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Lux Health Tech Acquisition's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lux Health Tech Acquisition's EV-to-EBIT falls into.



Lux Health Tech Acquisition EV-to-EBIT Calculation

Lux Health Tech Acquisition's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-1.12
=0.00

Lux Health Tech Acquisition's current Enterprise Value is $0.00 Mil.
Lux Health Tech Acquisition's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lux Health Tech Acquisition  (NAS:LUXAU) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lux Health Tech Acquisition's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2022 ) =EBIT / Enterprise Value (Q: Jun. 2022 )
=-1.12/0
= %

Lux Health Tech Acquisition's Enterprise Value for the quarter that ended in Jun. 2022 was $0.00 Mil.
Lux Health Tech Acquisition's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lux Health Tech Acquisition EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
920 Broadway, 11th Floor, New York, NY, USA, 10010
Lux Health Tech Acquisition Corp is a blank check company.
Executives
Frederic H Moll director C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo director, officer: Chief Executive Officer 1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert director, 10 percent owner C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh director C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough officer: CFO and Treasurer C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines